Mode
Text Size
Log in / Sign up
N/A N=111 Randomized Supportive Care

FitEx for Endometrial Cancer Survivors: Initial Efficacy

Endometrial Cancer · Obesity · Sedentary Behavior · Quality of Life · Survivorship

Enrolled (actual)
111
Serious AEs
0.0%
Results posted
May 2025
Primary outcome: Primary: Moderate to Vigorous Physical Activity of Endometrial Cancer Survivors — 3.7; 12.14; 3.15 minutes per day of MVPA

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Self-monitoring (Behavioral); Group-dynamics (Behavioral); Weekly virtual sessions- Standard (Behavioral); Newsletters- Standard (Behavioral); Newsletters- Yoga (Behavioral); Weekly virtual sessions- Yoga (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Carilion Clinic
Primary completion
Nov 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Moderate to Vigorous Physical Activity of Endometrial Cancer Survivors
3.7; 12.14; 3.15
SECONDARY
Quality of Life- Survivors
SECONDARY
Quality of Life Maintenance- Survivors
SECONDARY
Servings of Daily Fruits and Vegetables Maintenance- Survivors
SECONDARY
Servings of Daily Fruits and Vegetables- Survivors
SECONDARY
Flourishing- Survivors
SECONDARY
Flourishing Maintenance- Survivors
SECONDARY
Yoga Self-Efficacy- Survivors
SECONDARY
Yoga Self-Efficacy Maintenance- Survivors
SECONDARY
Social Support- Survivors
SECONDARY
Social Support Maintenance- Survivors
SECONDARY
Self-compassion- Survivors
SECONDARY
Self-compassion Maintenance- Survivors
SECONDARY
Habit Formation- Survivors
SECONDARY
Habit Formation Maintenance- Survivors
SECONDARY
Physical Activity Level (Active or Insufficiently Active) Maintenance- Survivors
SECONDARY
Physical Activity Level (Active or Insufficiently Active)- Survivors
SECONDARY
Moderate to Vigorous Physical Activity of Endometrial Cancer Survivors- Maintenance

Summary

The goal of this clinical trial is to compare physical activity outcomes between endometrial cancer survivors randomized to 1 of 3 conditions: 1) usual care, 2) FitEx, 3) FitEx+yoga. Survivors randomized to FitEx groups will recruit ~3 support team members to complete the intervention with them. The main question[s] it aims to answer are: * Do FitEx groups undertake more physical activity than the usual care group? * Are there differences in quality of life, self-compassion, flourishing, self-efficacy, social support, habit formation, and fruit /vegetable consumption Participants will: * Wear a Fitbit * Complete surveys * Participate in 30 minute weekly virtual meetings (FitEx groups only) * Receive weekly newsletters (FitEx groups only)

Eligibility Criteria

Inclusion Criteria

SURIVIVOR

  • Diagnosed with early stage (I-II) endometrial cancer, any histology
  • Received cancer care at Carilion Clinic after 1/1/2010
  • At least 18 years of age
  • Have adequate comprehension (reading and writing) of the English language
  • Have a BMI ≥ 30 kg/m^2 at screening
  • Have stable internet access or access to a smartphone with internet capabilities
  • Meet the requirements of the Physical Activity Readiness Questionnaire(PARQ)
  • Have the capacity to provide informed consent and are willing to provide informed consent
  • SUPPORT TEAM--
  • Were identified by a participant with endometrial cancer as a member of their support system
  • Are at least 18 years of age
  • Have adequate comprehension (reading and writing) of the English language
  • Have stable internet access or access to a smartphone with internet capabilities
  • Meet the requirements of the Physical Activity Readiness Questionnaire (PARQ)
  • Have the capacity to provide informed consent and are willing to provide informed consent

Exclusion Criteria

SURVIVOR

  • Recurrent endometrial cancer
  • Meeting physical activity guidelines set forth by the American Cancer Society at screening (greater than 150 minutes/week of moderate physical activity, or greater than 75 minutes/week of vigorous physical activity)
  • SUPPORT TEAM: Have functional limitations requiring a walker, wheelchair, scooter, or other walking aid which limits their capacity to engage in the intervention safely
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05737745). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search